Artemis Therapeutics, Inc. | Business Contracts

Form of Indemnification Agreement (Filed With SEC on November 21, 2022)

Personal Employment Agreement between Manuka Ltd. and Shimon Citron, dated April 13, 2022 (Filed With SEC on November 21, 2022)

First Amendment to the Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated June 30, 2022 (Filed With SEC on July 5, 2022)

English Translation of Agreement between Manuka Ltd. and Chic Cosmetic Industries 1987 Ltd., dated December 14, 2021 (Filed With SEC on July 5, 2022)

English Translation of Import License from the Israeli Ministry of Health, dated February 28, 2022 (Filed With SEC on July 5, 2022)

Form of Indemnification Agreement (Filed With SEC on September 21, 2022)

Service Agreement, dated as of July 26, 2022, by and between the Company and David Dana (Filed With SEC on August 2, 2022)

Certificate of Designation of Series D Convertible Preferred Stock (Filed With SEC on July 5, 2022)

Supply Agreement between Manuka Ltd. and Waitemata Honey Co. Ltd., dated July 20, 2021 (Filed With SEC on July 5, 2022)

Form of Warrant Exchange Agreement (Filed With SEC on July 5, 2022)

Form of Debt Forgiveness Agreement (Filed With SEC on July 5, 2022)

Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated March 6, 2022 (Filed With SEC on May 23, 2022)

Description of Securities (Filed With SEC on March 3, 2022)

Unsecured Promissory Note issued to KRNY Ltd (Filed With SEC on November 10, 2021)

Unsecured Promissory Note issued to Harmony (H.A.) Investments Ltd (Filed With SEC on November 10, 2021)

Form of Unsecured Promissory Note (Filed With SEC on August 19, 2019)

Artemis Therapeutics, Inc. (16)